Navigation Links
Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Date:8/27/2007

TORONTO, Aug. 27 /PRNewswire/ -- Drug Royalty LP 2 (DRC) announced today the purchase of 25% of Enzon Pharmaceuticals, Inc.'s (ENZN) worldwide royalty interest in PEG-INTRON for $92.5M. DRC will also provide a $15M milestone payment in 2012 should certain royalty recognition levels be met. PEG-INTRON (peginterferon alpha-2b), is approved for the treatment of Hepatitis C and is marketed worldwide by Schering-Plough Corporation (SGP).

Speaking on behalf of DRC, Paul Kirkconnell, Managing Director, said: "DRC is very pleased to be working with Enzon Pharmaceuticals. We believe that PEG- INTRON is one of the most advanced medications to treat Hepatitis C on the market today." Kirkconnell added, "With access to significant capital and a long track record in completing royalty transactions, we take pride in meeting the needs of pharmaceutical companies such as Enzon."

About PEG-INTRON(R)

PEG-INTRON is a PEG-enhanced version of Schering-Plough's alpha interferon product, INTRON(R) A, which is used both as a monotherapy and in combination with REBETOL(R) (ribavirin) capsules for the treatment of chronic hepatitis C. Under Enzon's license agreement with Schering-Plough, Schering-Plough holds an exclusive worldwide license to PEG-INTRON, and Enzon receives royalties on worldwide sales of PEG-INTRON. Schering-Plough is responsible for all manufacturing, marketing, and development activities for PEG-INTRON. Enzon designed PEG-INTRON to allow for less frequent dosing and to yield greater efficacy, as compared to INTRON A. PEG-INTRON is marketed worldwide by Schering-Plough and its affiliates.

About Drug Royalty Corporation, Inc. (DRC)

Drug Royalty Corporation ("DRC") is a privately held investment management company, focused on the healthcare industry, with over $1 billion under management. DRC currently manages two funds: the Royalty Monetization Fund and the Structured Finance Fund.

Its Royalty Monetization Fund acquires existing roya
'/>"/>

SOURCE Drug Royalty Corporation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Speaker announces business members of IT Task Force
11. Doyle announces technology tax credits for Berbee

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...wire-FirstCall/ -- Spherix Incorporated (Nasdaq: ... therapy, and a provider of technical and regulato...hnology and pharmaceutical companies, today announ...reholders. ,, At the meeting, shareholders of S...ollowing members to the Board of Directors: ,, ...
(Date:11/19/2009)...e Synthesis Companies Form International Gene Synt...es in Risk Reduction ,Five Member Companies Repr...ity , (PRWEB) November 19...ynthesis companies today announced agreement that ...mote biosecurity in the gene synthesis industry. ...
(Date:11/18/2009)...to find explosive materials and persons who have b...e National Institute of Standards and Technology (...d Security, has developed a new certified referenc..., Trace Particulate Explosives. Compatible with fi...helpful in calibrating, testing and developing sta...
(Date:11/18/2009)...swire-FirstCall/ -- Masimo (Nasdaq: MASI ), the...ough Motion and Low-Perfusion pulse oximetry, anno...of the largest healthcare Group Purchasing Organiz...rchasing agreement for "gold standard" Masimo SET ...ferred contract pricing to Uni.H.A.,s 53 member ho...
Breaking Biology Technology:Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4New NIST trace explosives standard slated for homeland security duty 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4
...ruck Drivers for Obstructive ...pnea Risk Evaluation System (ARES(TM)) Proven,to H...mize Litigation Risks, CARLSBAD, Calif., Sept. 5 ...ation company executives had to manage was the num...r laws were enacted in 2004,mandating that trucker...
...ader at Driving Growth, SAN FRANCISCO, Sept. 5 G...y firm that focuses on investments in selected seg...dustrial technology, business,services and softwar...urt,to the firm,s Strategic Advisory Board (SAB). ...Motion (Nasdaq: AIMC ), a former Genstar portfoli...
...esearch and process labs and offe.... 5 Sigma-Aldrich (Nasdaq:,SIAL), in association ...erence on laboratory compliance strategies on Sept...ce will review common U.S. federal laws,pertaining...ide attendees,with practical compliance solutions....
Other Biology Technology:Time For the Trucking and Heavy Machinery Industries to Wake Up! 2Time For the Trucking and Heavy Machinery Industries to Wake Up! 3Time For the Trucking and Heavy Machinery Industries to Wake Up! 4Time For the Trucking and Heavy Machinery Industries to Wake Up! 5Genstar Names Michael Hurt to Its Strategic Advisory Board 2Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 2Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 3
(Date:11/21/2009)...ed, Germany, November 20,2009 / b3c newswire / -...tion of a financing round, gaining two new investo...he same time KINAXO reports that Jrgen Schumacher ...dvisory board. , KINAXO shareholders Axel Ullric... companys institutional investors Mountain Partner...
(Date:11/20/2009)...ighly precise measurements of plasma lipoprotein c...ance spectroscopy (NMR), researchers led by Daniel...rd Medical School in Boston, MA, the Framingham He...ium in Stockholm, Sweden and Oxford, England perfo... genome among 17,296 women of European ancestry fr...
(Date:11/20/2009)...y question in the origin of biological molecules l...llions of years ago from simple precursors. Now, i...s in Italy have reconstructed one of the earliest ...RNA from individual subunits using nothing but war...s one of the first biological molecules present, b...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Genetic analysis helps dissect molecular basis of cardiovascular disease 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 1Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 3PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 1PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 2Better Than a Sweater for Christmas 59430 1Better Than a Sweater for Christmas 59430 2
... For cells that hold so much promise, stem cells, ...w research from Rockefeller University and Howard ... adult stem cells taken from skin can be used to c...r. The findings are reported in the Feb. 12 online...y of Sciences. , Embryonic stem cells have receive...
... The controversial idea that one cause of high blo...rt or blood vessels, has been put forward by scien...lished this week in the journal Hypertension. , Dr...y Professor Julian Paton, has found a novel role f...e-1), which is located in the walls of blood vesse...
... Nearly a century ago, John Scopes was found guilt...evolution in his classroom. Though an appeals cou..., the law lingered on the books, joined by later l...recently, "intelligent design." The battle to kee... life—especially human life—out of the science cur...
Other Biology News:Scientists clone mice from adult skin stem cells 2Scientists clone mice from adult skin stem cells 3Blame the brain for high blood pressure 2Fighting to keep Darwin in the classroom 2Fighting to keep Darwin in the classroom 3
Mouse Anti-Human NAP-2 Monoclonal Antibody, Unconjugated, Clone 5C7 from Santa Cruz Biotechnology, Inc.
...fication of cDNA ends) technique that improves the...NA ends. The GeneRacer Kit is available with Super...amplification of the full-length 5 end from long a...t II RT has been inactivated to avoid cleaving mRN...
EGY48 from Invitrogen
...on of single-stranded DNA and RNA endonucleolytica...le the nuclease prefers ssDNA over dsDNA by 30,000...ades double-stranded DNA from both ends (1,2). Mun...ng studies (3,4), for flushing staggered ends and ...
Biology Products: